AN2 Therapeutics, Inc.

Other Menlo Park, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Other
Headquarters
Menlo Park, CA
Street
1300 El Camino Real, Suite 100
Zip
94025

Offering

Total offering
$40M
Amount sold
$40M
First sale
Mar 10, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
16

How this filing compares

Ranked #29 of 222 Other filings in March 2026 by offering amount.

Median Other filing in March 2026: $5.4M. This offering is 7.4× the median.

Other California filings this week: 137 Holdings ISI, LLC, Am Tech Fund I LP, ARTELO BIOSCIENCES, INC., Be Bold Beverage, Inc., Calia 9 LLC

Leadership

Eric Easom — Executive Officer (also: Director)

Joshua Eizen — Executive Officer

Lucy Day — Executive Officer

Sanjay Chanda — Executive Officer

Joseph S. Zakrzewski — Director

Kabeer Aziz — Director

Rob Readnour — Director

Gilbert Lynn Marks — Director

Stephanie Wong — Director

Patricia Martin — Director

Melvin Spigelman — Director

Margaret FitzPatrick — Director

Filing details

AN2 Therapeutics, Inc. filed a Form D with the SEC on March 25, 2026.

Other newest Other companies

Other newest companies in California